Dermatologists say medication remains essential, but healthy daily routines may reduce flare-ups, ease discomfort, and ...

A businesswoman who has been affected by a rare skin condition since she was 12 found cutting one ingredient out of her diet ...

A businesswoman who has been affected by a rare skin condition since she was 12 found cutting one ingredient out of her diet ...

Powered by Mānuka honey, Melora's simple, natural approach to skincare has been praised by shoppers with psoriasis, eczema, ...

Johnson & Johnson Innovative Medicine names Tom Cavanaugh as its next EVP and Worldwide Chairman, succeeding retiring ...

Good morning, and thank you for standing by. Welcome to the AbbVie Second Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's call is also being recorded. If you have any objections ...

USA TODAY's first-ever Beauty & Wellness Awards for 2026 have arrived, and we're spotlighting the standout products ...

Nonsteroidal topicals like roflumilast are enabling proactive, long-term psoriasis control across a broad range of patients, reducing reliance on corticosteroids and minimizing the need for systemic ...

A panelist discusses how new data from the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) demonstrates tildrakizumab’s efficacy in treating nail psoriasis, with the 100-mg dose showing ...

Note: Prices listed are sourced from the manufacturers and accurate as of the publication date. Most Popular is calculated ...

Earnings call AbbVie delivered Q2 2026 adjusted EPS of $3.65 (up $0.06 vs guidance midpoint) and net revenues of nearly $17B (+10.2% YoY), driven by double-digit growth in immunology and neuroscience.